fluorodeoxyglucose f18 has been researched along with Nasopharyngeal Neoplasms in 203 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (2.96) | 18.2507 |
| 2000's | 65 (32.02) | 29.6817 |
| 2010's | 98 (48.28) | 24.3611 |
| 2020's | 34 (16.75) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, EN; Chen, WC; Liu, ZQ; OuYang, PY; Wu, YS; Xiao, SM; Xie, FY; Yang, SS; Zhang, BY; Zhang, J; Zhang, X | 1 |
| Gong, X; Jin, H; Lin, Y; Marks, T; Shan, H; Wan, J; Wang, S; Wang, Y; Yang, Y; Yao, J; Zhang, F; Zhang, W | 1 |
| Chen, H; Pang, Y; Shang, Q; Yu, Y; Zhao, L | 1 |
| Chen, C; Chen, T; Fei, Z; Hu, Y; Huang, C; Li, L; Liang, Z; Liu, J; Qiu, X; Xie, S; Xu, T; You, Z; Zheng, Y | 1 |
| Bergmark, RW; Guenette, JP; Jo, VY; Mishra, S; Miyawaki, EK; Schoenfeld, JD; Suh, CH; Uppaluri, R | 1 |
| Chen, Y; Fu, W; Liu, H; Yang, X | 1 |
| Vardhanabhuti, V; Xie, C | 1 |
| Jie, X; Shi, H; Xiu, Y; Xu, A | 1 |
| Chen, C; Fei, Z; Hu, Y; Huang, C; Li, L; Liang, Z; Liu, J; Qiu, X; Wu, H; Xie, S; Xu, T; Yi, L; You, Z; Zheng, Y | 1 |
| Blandino, A; Brogna, A; Cacciola, A; Ferini, G; Lillo, S; Minutoli, F; Parisi, S; Pergolizzi, S; Tamburella, C | 1 |
| Chen, D; Chen, W; Chen, Y; Lin, Z; Lou, Y; Song, L; Sun, J; Zhang, M | 1 |
| Chen, M; Chen, WM; Chiang, CW; Shia, BC; Wu, SY; Yang, PC | 1 |
| Chang, CC; Chi, YM; Liu, CT; Yen, WJ | 1 |
| Chen, CY; Fan, W; Guo, ZX; He, Y; Li, A; Li, J; Lin, QG; Liu, ZQ; OuYang, PY; Peng, QH; Wu, YS; Xiao, SM; Xie, CM; Xie, FY; Xu, SK; Yang, SS; Yao, WY; Zhang, BY; Zhang, X | 1 |
| Boldig, K; Montanarella, M; Natter, P; Ozdemir, S | 1 |
| Chen, C; Chen, J; Ding, J; Fei, Z; Hong, H; Huang, C; Li, L; Liu, J; Qiu, X; Xu, T; Xu, Y | 1 |
| Hu, C; Ou, X; Sun, C; Yan, W | 1 |
| Cao, C; Chen, S; Chen, X; Fang, Y; Huang, S; Qiang, M; Tao, C; Wang, L; Xu, Y | 1 |
| Lu, L; Lv, W; Wang, Q; Wu, Y; Xu, H; Yuan, Q; Zhang, H | 1 |
| Hu, F; Huang, J; Lan, X; Li, C; Wu, B; Xu, Y; Yang, K; Yang, Y | 1 |
| Chen, Y; Deng, J; Li, K; Liu, H; Xiang, F | 1 |
| Ahn, MJ; Ahn, YC; Choi, JY; Kim, SJ; Moon, SH | 1 |
| Cao, C; Chen, X; Huang, S; Qiang, M; Tao, C; Wang, L; Xu, Y | 1 |
| Huang, R; Liu, Y; Qi, M; Su, M | 1 |
| Bi, L; Feng, DD; Gu, B; Kim, J; Meng, M; Song, S; Xu, M | 1 |
| Chen, C; Chen, J; Ding, J; Fei, Z; Hong, J; Huang, C; Li, Z; Lin, Y; Zhou, Q | 1 |
| Chen, QY; Guo, SS; Li, XY; Liang, YJ; Liu, LT; Liu, SL; Mai, HQ; Sun, XS; Tang, LQ; Tang, QN; Wen, YF; Xie, HJ; Yan, JJ | 1 |
| Gao, L; Tian, Y; Wu, RY; Yang, YQ; Yi, JL | 1 |
| Chen, H; Chen, P; Fu, K; Liao, X; Lin, Q; Wang, Y; Zhao, L; Zhuang, Y; Zhuo, J | 1 |
| Amthauer, H; Bauersachs, L; Beck, M; Budach, V; Ehrhardt, VH; Hajiyianni, M; Hartmann, V; Hofheinz, F; Kalinauskaite, G; Li, Y; Lin, Q; Rogasch, J; Stromberger, C; van den Hoff, J; Weingärtner, J; Zschaeck, S | 1 |
| Abdulrezzak, U; Basaran, H; Dogan, S; Gundog, M | 1 |
| Chen, QY; Guo, SS; Jia, GD; Liu, LT; Liu, SL; Luo, DH; Mai, HQ; Sun, R; Sun, XS; Tang, LQ; Xie, HJ; Yu, YF | 1 |
| Chen, QY; Fan, W; Guo, L; Guo, SS; Han, LJ; Li, JB; Li, XY; Liang, YJ; Lin, C; Lin, DF; Liu, LT; Liu, SL; Luo, DH; Lv, XF; Mai, HQ; Sun, R; Sun, XS; Tang, LQ; Tang, QN; Wen, YF; Xiao, BB; Yuan, L; Zhang, X | 1 |
| Chen, QY; Fan, W; Guo, L; Guo, SS; Han, LJ; Li, JB; Li, XY; Liang, YJ; Lin, DF; Liu, LT; Liu, SL; Luo, DH; Lv, XF; Mai, HQ; Sun, R; Sun, XS; Tang, LQ; Tang, QN; Wen, YF; Xiao, BB; Yuan, L; Zhang, X | 1 |
| Cao, C; Chen, X; Hu, Q; Hua, Y; Huang, S; Jiang, F; Jin, Q; Jin, T; Piao, Y; Xu, Y | 1 |
| Feng, M; He, Q; Huang, Y; Jiang, Q; Lang, J; Xu, P; Yin, J | 1 |
| Han, YQ; He, Q; Hu, Y; Li, Y; Liu, F; Liu, L; Luo, L; Ma, HZ; Mo, Y; Wang, H; Xi, XP; Xiao, F; Xiao, Q; Zhang, L | 1 |
| Cheng, ZB; Jin, YN; Ma, J; Mo, HY; Sun, Y; Wang, SY; Yao, JJ; Zhang, F; Zhang, WJ; Zhou, GQ | 1 |
| Chen, H; Chen, Y; He, S; Hong, S; Liang, S; Peng, P; Wang, Y; Xia, L; Yang, L | 1 |
| Chen, M; Chen, X; Rong, L; Sun, Q; Sun, Y; Wu, Q; Xu, H; Zhu, D | 1 |
| Chen, L; Guo, R; Guo, Y; Li, WF; Lin, XP; Liu, LZ; Ma, J; Mao, YP; Peng, H; Sun, Y; Tang, LL; Tian, L; Zhang, X; Zhang, Y | 1 |
| Chen, W; Feng, Q; Jiang, J; Lu, L; Lv, W; Ma, J; Rahmim, A; Wang, Q; Yang, W; Yuan, Q | 1 |
| Chan, AT; Chan, CM; Chan, KCA; Hui, EP; Kam, MK; King, A; Leung, SF; Li, L; Lo, YMD; Loong, H; Ma, B; Mo, F; Wang, K; Wong, A; Wong, SCC | 1 |
| Cho, H; Choi, EC; Kim, H; Kim, SH; Koh, YW; Yun, M | 1 |
| Chen, XY; Luo, QY; Zhang, GQ; Zhang, XY | 1 |
| Chang, SK; Jeong, Y; Jung, IH; Kim, JS; Lee, SW | 1 |
| Chan, SC; Chang, JT; Chang, KP; Chen, YH; Chu, SC; Hsu, CL; Liu, SH; Ng, SH; Wang, LY; Yen, TC | 1 |
| Alessi, A; Alfieri, S; Bossi, P; Cavallo, A; Cicchetti, A; Colombo, CB; Crippa, F; Fallai, C; Iacovelli, NA; Licitra, L; Lorenzoni, A; Mira, M; Orlandi, E; Padovano, B; Serafini, G | 1 |
| Cao, C; Chen, X; Hu, Q; Niu, T; Xu, Y; Yang, P | 1 |
| Abgral, R; Benoudiba, F; de Mones, E; Garcia, G; Garrel, R; Mouawad, F; Pondaven, S; Russ, G; Rysman, B; Tronche, S; Zerdoud, S | 1 |
| Chen, C; Chen, T; Fei, Z; Huang, Y; Li, L; Li, Y; Qiu, X | 1 |
| Dong, ZR; Li, T; Zhi, XT | 1 |
| Chan, JY; Chow, VL; Wei, WI; Wong, ST | 1 |
| Chan, SC; Chang, JT; Chang, KP; Hsu, CL; Kuo, WH; Liao, CT; Lin, CY; Lin, YJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Khong, PL; Lai, V | 1 |
| Julian, J; Levine, MN | 1 |
| Cao, KJ; Cao, Y; Chen, MY; Chen, QY; Fan, W; Guo, L; Guo, X; Hua, YJ; Huang, PY; Li, J; Lin, XP; Liu, H; Liu, LZ; Luo, DH; Lv, X; Mai, HQ; Mo, HY; Mo, YX; Qian, CN; Qiu, F; Sun, R; Tang, LQ; Wang, L; Xiang, YQ; Zeng, MS; Zhang, L; Zhang, X; Zhao, C; Zou, RH | 1 |
| Khoo, JB; Tan, NC; Teo, PT | 1 |
| Hu, C; Hu, S; Li, D; Pan, H; Shi, W; Yang, Z; Yao, Z; Zhang, Y; Zhu, B | 1 |
| Chen, YK; Cheng, RH; Chia-Hung, K; Tsui, CC; Wang, SC; Yeh, CL | 1 |
| Han, J; Hu, S; Ke, S; Lei, G; Li, C; Liu, Z; Lu, M; Ran, H; Wang, W; Yang, G; Zhang, F; Zhang, T; Zhang, W; Zhang, Y; Zou, C | 1 |
| Basturk, A; Kilicarslan, A; Ozdemir, E; Turkolmez, S; Yildirim-Poyraz, N | 1 |
| Kang, H; Marcus, C; Mohandas, A; Subramaniam, RM; Truong, MT | 1 |
| Hu, C; Shi, Q; Yang, Z; Zhang, Y | 1 |
| Cho, KS; Hong, SL; Kim, SJ; Lee, SH; Roh, HJ; Yoon, YH | 1 |
| Deng, H; Jia, Z; Li, J; Shen, G; Wang, Q; Zhang, W | 1 |
| Cai, L; Chen, Y; Huang, Z; Wu, J; Zhang, Y | 1 |
| Hu, C; Hu, S; Pan, H; Shi, Q; Shi, W; Yang, Z; Yao, Z; Zhang, Y; Zhu, B | 1 |
| Goh, BC; Khor, LK; Loh, KS; Loi, HY; Lu, SJ; Sinha, AK; Tong, KT | 2 |
| Chen, QY; Guo, SS; Guo, X; Li, PJ; Liu, LT; Luo, DH; Mai, DM; Mai, HQ; Mo, HY; Qian, CN; Shen, T; Tang, LQ; Zeng, MS | 1 |
| Chen, TT; Chiu, CF; Hsieh, CY; Hsieh, TC; Hua, CH; Lin, CC; Lin, CY; Sher, YP; Yang, TY; Yeh, SP | 1 |
| Deng, H; Jia, Z; Shen, G; Wang, Q; Zhang, W; Zhou, L | 1 |
| Chen, L; Hu, W; Wang, Y; Wei, G; Xian, W; Zhang, N | 1 |
| Lin, R; Su, M; Wei, H; Zhang, X; Zhao, L; Zou, C | 1 |
| Huang, B; Khong, PL; Kwong, DL; Lai, V; Wong, CY | 1 |
| Chen, W; Feng, Q; Huang, M; Jiang, J; Wang, Q; Wu, H; Wu, Y; Yang, W; Zhao, J | 1 |
| Al Tamimi, AS; Ng, DC; Osmany, S; Zaheer, S | 1 |
| Chu, YH; Hsu, CC; Huang, WY; Lee, JC; Lin, CK; Shu, YC; Tsai, MC | 1 |
| Galaverni, M; Grondelli, C; Iotti, C; Liguoro, M; Micera, R; Pagano, M; Roncali, M; Simoni, N; Vigo, F | 1 |
| Cao, KJ; Chen, QY; Chen, WH; Fan, W; Guo, L; Guo, SS; Guo, X; Liu, LT; Mai, HQ; Qian, CN; Tang, LQ; Xie, D; Zeng, MS; Zhang, L; Zhang, X; Zhao, C | 1 |
| Cai, H; Li, L; Shen, G; Zhang, W; Zhou, H; Zhou, Y | 1 |
| Pei, S; Wei, J; Zhu, X | 1 |
| Chen, S; Fang, F; Huo, Y; Ma, C; Wang, H; Wang, S; Wu, S; Wu, Z; Ye, Z; Zou, R | 1 |
| Cho, BC; Keum, KC; Kim, KH; Lee, CG; Lee, J; Roh, YH; Yoon, HI; Yun, M | 1 |
| Chan, HY; Ho, JC; Lee, EY; Tsoi, A; Wong, MP | 1 |
| Glaas, MF; Knapp, F; Schipper, J; Suttorp, AC | 1 |
| Chen, YZ; Li, WF; Ou, RY; Wang, JM; Wang, JY; Xu, YS; Zhao, L; Zheng, XW | 1 |
| Chen, L; Li, WF; Liu, Q; Ma, J; Mao, YP; Peng, H; Sun, Y; Zhang, Y; Zhou, GQ | 1 |
| Cheng, W; Cui, Y; Hai, W; Liang, S; Liu, H; Wang, D; Yin, B; Zhang, C | 1 |
| Bray, V; Chicco, A; Forstner, D; Fowler, A; Holloway, L; Lee, M; Lin, P; Min, M; Xuan, W | 1 |
| Chan, SC; Chang, KP; Fang, YD; Hsu, CL; Liao, CT; Ng, SH; Tsang, NM; Yen, TC | 1 |
| Abdulelah, H; Al-Hussaini, M; Al-Ibraheem, A; AlSharif, A | 1 |
| Ahn, MJ; Ahn, YC; Cho, YS; Choi, JY; Kim, BT; Lee, KH; Moon, SH; Son, YI | 1 |
| Kang, S | 1 |
| Li, H; Liao, G; Lin, J; Wang, B; Xie, G; Yan, M; Yuan, Y | 1 |
| Balestreri, L; Borsatti, E; Cimitan, M; Comoretto, M; Franchin, G; Lise, M | 1 |
| Chen, MY; Fan, W; Liang, PY; Lin, XP; Zhang, X; Zhao, C; Zhi, SF | 1 |
| Chang, MC; Lin, WY; Tsai, SC | 1 |
| Li, J; Li, XD; Pan, YD; Yin, JL | 1 |
| Chua, ET; Chua, ML; Fong, KW; Gao, F; Khoo, JB; Low, JS; Ng, DC; Ong, SC; Tan, TW; Wee, JT | 1 |
| Borkar, S; Ghossein, RA; Schöder, H; Singh, B; Yoshida, A | 1 |
| Chen, TH; Chien, CR; Hong, RL; Tzen, KY; Yen, MF; Yen, RF | 1 |
| Alberini, JL; Banal, A; Floiras, JL; Gardner, M; Halimi, P; Hans, S; Housset, M; Labib, A; Plantet, MM; Valinta, D; Wartski, M | 1 |
| Cheng, MF; Hong, RL; Ting, LL; Tzen, KY; Wu, YW; Yen, RF | 1 |
| Chan, SC; Chang, JT; Chen, MC; Ko, SF; Liao, CT; Ng, SH; Wai, YY; Wang, HM; Wang, JJ; Yen, TC | 1 |
| Hsieh, TC; Kao, CH; Liang, JA; Lin, YY; Sun, SS; Wang, CH; Wu, YC; Yen, KY | 1 |
| Fan, W; Hu, YY; Liang, PY; Lin, XP; Zhang, WG; Zhang, X | 1 |
| Balogh, J; Caldwell, C; Khaouam, N; MacKenzie, R; Mah, K; Poon, I; Tirona, R; Yu, H | 1 |
| Fan, YX; Gao, MJ; Li, J; Li, KB; Liu, QZ; Shi, WM; Wu, JZ; Yang, CH; Yin, JL | 1 |
| Feng, R; Fu, Z; Xie, P; Yu, JM; Yue, JB | 1 |
| Fu, Z; Kong, L; Sun, XD; Xie, P; Yu, JM; Yue, JB; Zhao, HX | 1 |
| Chan, WK; Huang, B; Khong, PL; Kwong, DL; Mak, HK; Yeung, DW | 1 |
| Hsiung, CY; Huang, ML; Hung, GU; Lin, ST | 1 |
| Fen, YL; He, XH; Xian, WJ; Ye, QL; Yuan, BH; Yuan, JW | 1 |
| Chan, SC; Chang, JT; Chang, KP; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Yen, TC | 1 |
| Kim, KS | 1 |
| Bakhshi, S; Karunanithi, S; Radhakrishnan, V; Tanveer, N; Thulkar, S | 1 |
| Fang, J; Luo, XM; Ruan, LX; Yan, SX; Yao, HT; Zhou, SH | 1 |
| Fury, MG; Jansen, JF; Koutcher, JA; Lee, NY; Patel, SG; Pfister, DG; Schöder, H; Shah, JP; Shukla-Dave, A; Stambuk, HE; Wang, Y | 1 |
| Lee, JK; Li, YC; Liu, JT; Liu, WS; Tseng, HC; Weng, JH; Wu, MF | 1 |
| Li, HS; Wang, MF; Wang, QS; Wu, HB; Zhen, X; Zhou, WL | 1 |
| Chen, KW; Jiang, RS; Liang, KL; Lin, JC; Lin, WY; Shih, YT; Twu, CW; Wang, WY; Wu, CT | 1 |
| Corry, J; Drummond, E; Dutu, G; Lau, E; Law, A; Peters, LJ; Rischin, D | 1 |
| Chan, JY; Chow, VL; Ho, AC; Mok, VW; Wei, WI | 1 |
| Chen, HC; Chen, MK; Hung, GU; Lee, HS; Wu, IS; You, WC | 1 |
| Ng, DC; Tan, AE | 1 |
| Chan, SC; Chang, CJ; Chang, JT; Liao, CT; Lin, CY; Lin, SY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Chen, ZP; Lu, YC; Mou, YG; Sai, K; Wang, ZN; Wei, DN; Yang, QY; Zhang, XH | 1 |
| Chan, WK; Huang, B; Khong, PL; Kwong, DL; Yeung, DW | 1 |
| Dong, MJ; Liu, ZF; Sun, ML; Wang, GL; Wang, HT; Yang, SY; Zhao, K | 1 |
| Hsieh, TC; Hsu, CN; Kao, CH; Sun, SS; Wu, YC; Yang, CF; Yen, KY | 1 |
| Huang, B; Hung, B; Khong, PL; Kwong, DL; Wong, CS; Wong, CY | 1 |
| Chan, SC; Chang, KP; Chung, MJ; Hsu, CL; Liao, CT; Lo, CW; Ng, SH; Tsang, NM; Wang, HM; Yen, TC | 1 |
| Chan, T; Khong, PL; Wu, B | 1 |
| Bengua, G; Hasegawa, M; Ishikawa, M; Katoh, N; Onimaru, R; Shiga, T; Shimizu, S; Shirato, H; Tamaki, N; Yasuda, K | 1 |
| Cho, KS; Kang, DW; Kim, HJ; Lee, JK; Roh, HJ | 1 |
| Lin, JC; Lin, PJ; Wang, WY | 1 |
| Cheuk, DK; Hossain, M; Krasin, MJ; Naik, M; Rodriguez-Galindo, C; Sabin, ND; Shulkin, BL; Wozniak, A | 1 |
| Chen, S; Lin, Q; Sun, L; Wu, H; Yang, R | 1 |
| Chan, T; Chan, WK; Huang, B; Khong, PL; Kwong, DL | 1 |
| Dai, MM; Li, YM; Lin, Q; Luo, ZM; Sun, L; Wang, LC; Wu, H; Yang, RS; Zhao, L | 1 |
| Li, S; Li, X; Liang, B; Lin, S; Liu, X; Lu, J; Peng, X; Wu, H; Yu, L | 1 |
| Chan, SC; Hsu, CL; Liao, CT; Ng, SH; Wang, HM; Yen, TC | 1 |
| Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
| Chan, SC; Chang, JT; Chen, IH; Fan, KH; Huang, SF; Hung, TM; Kang, CJ; Liao, CT; Lin, CY; Ng, SH; Wang, HM | 1 |
| Chang, MC; Chen, JH; Cheng, KY; Kao, CH; Liang, JA; Yang, KT | 1 |
| Chen, YR; Gu, MX; Li, WX; Pan, Y | 1 |
| Chen, LH; Wu, DH | 1 |
| Huang, KM; Hung, RL; Kao, CH; Lui, LT; Pan, MH; Wang, YH; Yen, RF | 1 |
| Bajzik, G; Csere, T; Esik, O; Lengyel, E; Lengyel, Z; Olajos, J; Sáfrány, G; Stefanits, K; Szakáll, S; Trón, L; Vönöczky, K | 1 |
| Chan, SC; Chang, JT; Chang, YC; Ko, SF; Liao, CT; Ng, SH; Wang, HM; Yen, TC | 1 |
| Chan, SC; Chang, JT; Liu, SH; Ng, SH; Yen, TC | 1 |
| Chan, SC; Chang, YC; Fu, YK; Joseph, CT; Ko, SF; Liao, CT; Lin, WJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Dai, JZ; Dong, MJ; Guan, YH; Lin, XT; Yu, DF; Zhao, J; Zuo, CT | 1 |
| Chan, SC; Chang, JT; Chen, TM; Ng, SH; Tzu-Chen, Y | 1 |
| Chan, SC; Chang, JT; Chang, YC; Fu, YK; Hsu, CH; Lin, KJ; Lin, WJ; Ng, SH; Yen, TC | 1 |
| Chan, SC; Chang, JT; Chang, YC; Fu, YK; Lin, CY; Lin, KJ; Lin, WJ; Ng, SH; Yen, TC | 1 |
| Chen, TH; Hong, RL; Pan, MH; Tzen, KY; Yen, RF | 1 |
| Chan, SC; Chang, JT; Chang, YC; Chen, IH; Chen, TM; Kang, CJ; Liao, CT; Lin, CY; Lin, KJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Chen, TH; Hong, RL; Pan, MH; Ting, LL; Tzen, KY; Yen, RF | 1 |
| Hung, GU; Lin, WY; Tsai, SC | 1 |
| Alavi, A; Hustinx, R; Zhuang, H | 1 |
| Chen, LH; Ding, Y; Wu, DH | 1 |
| Chan, SC; Chang, JT; Kang, CJ; Liao, CT; Liu, FY; Ng, SH; Ng, SK; Wang, HM; Yen, TC | 1 |
| Aschoff, P; Bihl, H; Hagen, R; Schneider, K | 1 |
| Chan, SC; Chang, JT; Chang, YC; Chen, YC; Hsu, CL; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Cui, NJ; Han, F; Lu, LX; Lu, TX; Su, Y; Sun, Y; Wu, HB; Xie, CM; Zeng, ZY; Zhao, C | 1 |
| Chen, LH; Wang, QS; Wu, FB; Zheng, XK | 1 |
| Muzik, O; Peng, F; Rabkin, G | 1 |
| Jing-bo, Z; Li-xia, Y; Yan, Z | 1 |
| Chan, SC; Chang, JT; Chen, IH; Cheng, AJ; Fan, KH; Huang, SF; Kang, CJ; Liao, CT; Lin, CY; Lin, WJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Chan, SC; Chang, JT; Fan, KH; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Chen, QJ; Chen, Y; Huang, SQ; Huang, XM; Lu, TX; Sun, W; Zeng, L; Zheng, YQ | 1 |
| Ahuja, A; Chan, AT; Hui, EP; Kam, MK; King, A; Kwan, WH; Leung, SF; Lo, YM; Ma, BB; Mo, F; Yau, YY; Zee, B | 1 |
| Chan, AT; Chan, SL; Hui, EP; Leung, SF; Ma, BB | 1 |
| Chen, YK; Cheng, RH; Chi, KH; Hsu, CH; Su, CT; Wang, SC | 1 |
| Bar-Shalom, R; Daitzchman, M; Golz, A; Gordin, A; Israel, O; Keidar, Z; Kuten, A | 1 |
| Alavi, A; Basu, S | 1 |
| Huang, XM; Li, WH; Zeng, L | 1 |
| Binns, DS; Drummond, E; Hicks, RJ; Hogg, A; Lau, EW; Shakher, R; Wang, GH | 1 |
| Chen, Y; Cui, NJ; Ma, J; Sun, Y; Tang, LL; Wang, Y; Wu, HB; Zong, JF | 1 |
| Chen, LH; Chen, YQ; Li, QS; Wang, HM; Wang, QS; Wu, HB; Xu, YK; Yan, WP; Zheng, XK | 1 |
| Chan, SC; Chang, JT; Chin, SC; Liao, CT; Lin, CY; Liu, FY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Bai, YR; Huang, G; Liu, T; Xu, W; Yan, WL; Ye, M | 1 |
| Ahn, SD; Choi, EK; Im, KC; Kim, JH; Kim, JS; Kim, SY; Lee, BJ; Lee, SW; Nam, SY; Park, SH | 1 |
| Ng, DC; Osmany, S; Padhy, AK | 1 |
| Ahuja, AT; Chan, AT; Kam, MK; King, AD; Leung, SF; Ma, BB; Wong, JK; Yau, YY; Zee, B | 1 |
| Chan, AT; Hui, EP; King, AD; Leung, SF; Lo, YM; Ma, BB; Mo, FK; Yau, YY | 1 |
| Chan, SC; Chang, JT; Chin, SC; Fan, KH; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Bhargava, P; Dezube, BJ; Parker, JA | 1 |
| Black, M; Gjedde, A; Yamamoto, YL; Zeitouni, AG | 1 |
| Nakai, Y; Ochi, H; Ohashi, Y; Okamura, T; Sakamoto, H | 1 |
| AAssar, OS; Caputo, GR; Dillon, WP; Fischbein, NJ; Hawkins, RA; Kaplan, MJ; Price, DC; Singer, MI | 1 |
| ChangLai, SP; Chieng, PU; Kao, CH; Yen, RF; Yen, TC | 1 |
| Eckel, H; Jungehülsing, M; Pietrzyk, U; Scheidhauer, K; Schicha, H | 1 |
| Kuwert, T | 1 |
| Chisin, R; Nuñez, RF; Yeung, HW | 1 |
| Asaka, M; Imamura, M; Kato, T; Kobayashi, S; Nishioka, T; Shirato, H; Tamaki, N; Tsukamoto, E; Yamazaki, A | 1 |
| ChangLai, SP; Chieng, PU; Ho, YJ; Hsieh, JF; Kao, CH; Tsai, SC; Yen, RF | 1 |
| Ho, ST; Ho, YJ; Kao, CH; Tsai, SC; Wang, JJ; Yen, RF | 1 |
| Kao, CH; Shen, YY; Shiau, YC; Yen, RF | 1 |
| Kao, CH; Lee, CC; Lin, CC; Shen, YY; Shiau, YC; Tsai, MH | 1 |
16 review(s) available for fluorodeoxyglucose f18 and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Imaging features, therapies, and outcomes of fibrosing inflammatory pseudotumor of the nasopharynx: A systematic review.
Topics: Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Granuloma, Plasma Cell; Humans; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Nasopharynx; Positron Emission Tomography Computed Tomography | 2022 |
PET/CT: Nasopharyngeal Cancers.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2022 |
Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Observational Studies as Topic; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2017 |
Cervical metastasis of gingival carcinoma misdiagnosed as branchiogenic carcinoma, a rare entity - report of a case and review of literature.
Topics: Branchioma; Carcinoma, Squamous Cell; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Lymphatic Metastasis; Middle Aged; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Imaging appearances for recurrent nasopharyngeal carcinoma and post-salvage nasopharyngectomy.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
FDG PET/CT in the management of nasopharyngeal carcinoma.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2014 |
Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
[Meta-analysis of PET/CT for diagnosis of residual/recurrent nasopharyngeal carcinoma].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT for the Diagnosis of Residual or Recurrent Nasopharyngeal Carcinoma After Radiotherapy: A Metaanalysis.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2016 |
Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2016 |
Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Publication Bias; ROC Curve | 2017 |
Expression of glucose transporter-1, hypoxia-inducible factor-1α, phosphatidylinositol 3-kinase and protein kinase B (Akt) in relation to [(18)F]fluorodeoxyglucose uptake in nasopharyngeal diffuse large B-cell lymphoma: a case report and literature review
Topics: Adult; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Nasopharyngeal Neoplasms; Nasopharynx; Phosphatidylinositol 3-Kinase; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Tomography, X-Ray Computed | 2010 |
Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient.
Topics: Adult; Carcinoma, Squamous Cell; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Middle Aged; Nasopharyngeal Neoplasms; Osteoradionecrosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
[Diagnostic and therapeutic application of 18F-fluoro-deoxy-glucose PET in carcinoma of nasopharynx].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Positron-Emission Tomography | 2006 |
FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
17 trial(s) available for fluorodeoxyglucose f18 and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
The prognostic value of radiomic features from pre- and post-treatment
Topics: Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2023 |
Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; DNA, Viral; Drug Monitoring; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Response Evaluation Criteria in Solid Tumors; Time Factors; Treatment Outcome; Tumor Burden; Viral Load | 2018 |
Utility of 18F-FDG uptake in various regions of Waldeyer's ring to differentiate benign from malignant lesions in the midline roof of the nasopharynx.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2014 |
Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Diagnostic Imaging; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Primary tumor volume measured by FDG PET and CT in nasopharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma.
Topics: Biomarkers, Tumor; Carcinoma; DNA, Viral; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Treatment Outcome; Viral Load | 2012 |
PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Biological response of nasopharyngeal carcinoma to radiation therapy: a pilot study using serial 18F-FDG PET/CT scans.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2012 |
Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Taiwan | 2004 |
Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Whole-Body Counting | 2005 |
Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Taiwan; Treatment Outcome; Whole Body Imaging | 2005 |
Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging.
Topics: Adult; Brachytherapy; Diagnostic Errors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiother
Topics: Adolescent; Adult; Aged; Carcinoma; Diagnosis, Differential; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2001 |
Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission
Topics: Adolescent; Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
170 other study(ies) available for fluorodeoxyglucose f18 and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma.
Topics: Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymph Nodes; Lymphatic Metastasis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity | 2022 |
The Role of Pretreatment
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Young Adult | 2021 |
68Ga-FAPI PET/CT Distinguishes the Reactive Lymph Nodes From Tumor Metastatic Lymph Nodes in a Patient With Nasopharyngeal Carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Selectively recommend
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; DNA, Viral; Endemic Diseases; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2021 |
Increased 68Ga-FAPI Uptake in Avascular Necrosis of Femoral Head in a Patient With Nasopharyngeal Carcinoma.
Topics: Aged; Femur Head; Femur Head Necrosis; Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Solitary Nasopharyngeal Metastasis From Papillary Thyroid Carcinoma Shown on FDG PET/CT.
Topics: Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Nasopharynx; Positron Emission Tomography Computed Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2022 |
Reflecting on the utility of standardized uptake values on
Topics: Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Intensity-modulated radiotherapy does not induce volumetric changes of the Bichat fat pad in nasopharyngeal cancer.
Topics: Adipose Tissue; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies | 2022 |
The prognostic value of the ratio of standard uptake value of lymph node to primary tumor before treatment of locally advanced nasopharyngeal carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Survival effect of pretreatment FDG-PET-CT on nasopharyngeal cancer.
Topics: Cohort Studies; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Skeletal scintigraphy as an important complement for detecting bone metastasis from nasopharyngeal carcinoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals | 2022 |
Benefit of [
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Salvage Therapy; Sensitivity and Specificity | 2023 |
18 F-FDG PET/CT Findings of Leptomeningeal Metastasis in Nasopharyngeal Carcinoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Meningeal Carcinomatosis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma.
Topics: ErbB Receptors; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Failure | 2023 |
Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy.
Topics: Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Assessment of bone lesions with 18 F-FDG PET/MRI in patients with nasopharyngeal carcinoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Multimodality radiomics analysis based on [
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Evaluation of 11 C-Choline PET/CT for T Staging and Tumor Volume Delineation in Nasopharyngeal Cancer Patients in Comparison to 18 F-FDG PET/CT.
Topics: Choline; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden | 2023 |
Early Detection of Gastric Intramucosal Adenocarcinoma on 68 Ga-FAPI PET/CT.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2023 |
The impact of the COVID-19 pandemic on nasopharyngeal carcinoma extent at FDG PET/MR staging: The NPCOVIPET study.
Topics: COVID-19; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Pandemics; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Primary Hepatocellular Carcinoma Revealed on 68 Ga-DOTATATE in a Patient With Nasopharyngeal Carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies | 2023 |
Multi-task deep learning-based radiomic nomogram for prognostic prediction in locoregionally advanced nasopharyngeal carcinoma.
Topics: Deep Learning; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Radiomics-clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nomograms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Maximal standard uptake values of
Topics: Adult; Aged; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; ROC Curve | 2019 |
[The key role of PET/CT for diagnosis and evaluation of treatment response in a patient with simultaneous nasopharyngeal cancer and tuberculous mediastinal lymphadenitis: a case report].
Topics: Fluorodeoxyglucose F18; Humans; Lymphadenitis; Mediastinal Diseases; Mediastinum; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Treatment Outcome; Tuberculosis, Lymph Node | 2019 |
Usefulness of [
Topics: B7-H1 Antigen; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2020 |
Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; International Agencies; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden | 2020 |
MR-guided simulation is superior than FDG/PET-guided simulation for local control in nasopharyngeal cancer patients treated with intensity-modulated radiotherapy.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiotherapy, Intensity-Modulated; Retrospective Studies; Young Adult | 2021 |
Identifying optimal candidates for induction chemotherapy among stage II-IVa nasopharyngeal carcinoma based on pretreatment Epstein-Barr virus DNA and nodal maximal standard uptake values of [
Topics: Clinical Decision-Making; Disease Progression; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Time Factors | 2020 |
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Topics: Case-Control Studies; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis | 2021 |
Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2017 |
Prognostic value of primary gross tumor volume and standardized uptake value of
Topics: Adult; Aged; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Young Adult | 2017 |
Significant value of
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiotherapy, Intensity-Modulated; ROC Curve; Treatment Outcome; Young Adult | 2017 |
Robustness versus disease differentiation when varying parameter settings in radiomics features: application to nasopharyngeal PET/CT.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharyngitis; Positron Emission Tomography Computed Tomography; Radiometry; ROC Curve; Young Adult | 2018 |
Lymph Node With the Highest FDG Uptake Predicts Distant Metastasis-Free Survival in Patients With Locally Advanced Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Analysis | 2018 |
Diffuse Liver Metastasis From Nasopharyngeal Carcinoma Found by 18F-FDG PET/CT Scans.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography | 2018 |
Clinical significance of the post-radiotherapy
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Young Adult | 2019 |
Value of early evaluation of treatment response using
Topics: Adult; DNA, Viral; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome | 2019 |
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Combined Modality Therapy; DNA, Viral; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Treatment Outcome; Viral Load; Whole Body Imaging | 2019 |
Feasibility of multiparametric imaging with PET/MR in nasopharyngeal carcinoma: A pilot study.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2019 |
Cystic form of cervical lymphadenopathy. Guidelines of the French Society of Otorhinolaryngology - Head and Neck Surgery (SFORL). Part 1: Diagnostic procedures for lymphadenopathy in case of cervical mass with cystic aspect.
Topics: Adult; Biopsy, Fine-Needle; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image-Guided Biopsy; Lymphadenopathy; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2019 |
Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; Retrospective Studies; Survival Analysis; Tumor Burden; Young Adult | 2019 |
A Rapidly Progressing Polycystic Liver Disease?
Topics: Biopsy; Cysts; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Liver; Liver Diseases; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Nasal Cavity; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Time Factors | 2020 |
Surgical salvage for recurrent retropharyngeal lymph node metastasis in nasopharyngeal carcinoma.
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Pharynx; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Salvage Therapy | 2013 |
Prognostic implications of post-therapy (18)F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Topics: Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Treatment Failure | 2013 |
Updates on MR imaging and ¹⁸F-FDG PET/CT imaging in nasopharyngeal carcinoma.
Topics: Adult; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Selective application of a test based on risk: using limited resources wisely.
Topics: Carcinoma; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radionuclide Imaging | 2013 |
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
Topics: Carcinoma; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2013 |
Is 18F-FDG PET/CT more reliable than 99mTc-MDP planar bone scintigraphy in detecting bone metastasis in nasopharyngeal carcinoma?
Topics: Adult; Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Young Adult | 2014 |
Multi-modality imaging to determine the cellular heterogeneity of nasopharyngeal carcinoma components.
Topics: Animals; Carcinoma; Cell Line, Tumor; Contrast Media; Fluorodeoxyglucose F18; Heterografts; Humans; Mice; Mice, Nude; Microscopy, Confocal; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiopharmaceuticals | 2014 |
PET/CT findings in a case with FDG-avid disseminated lacrimal gland MALToma with sequential development of large B-cell lymphoma and gastric MALToma.
Topics: Aged; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Adding maximum standard uptake value of primary lesion and lymph nodes in 18F-fluorodeoxyglucose PET helps predict distant metastasis in patients with nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Prognostic value of metabolic tumor volume as measured by fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2014 |
Nasopharyngeal tuberculosis mimicking nasopharyngeal carcinoma on (18)F-FDG PET/CT in a young patient.
Topics: Adult; Carcinoma; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis, Laryngeal | 2015 |
Pretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma--a retrospective study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Correlation between (68)Ga-DOTA-NOC PET/CT and (18)F-FDG PET/CT in EBV-positive undifferentiated nasopharyngeal carcinoma.
Topics: Adult; Carcinoma; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.
Topics: Adolescent; Adult; Aged; Carcinoma; Child; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2015 |
[18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiography; Survival Rate | 2015 |
[Value of FDG PET-CT associated with pathology in diagnosing residual tumor in patients with nasopharyngeal carcinoma after radiotherapy].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-fluorodeoxyglucose positron emission tomography for predicting tumor response to radiochemotherapy in nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiotherapy, Intensity-Modulated | 2015 |
Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography | 2015 |
Variability of Gross Tumor Volume in Nasopharyngeal Carcinoma Using 11C-Choline and 18F-FDG PET/CT.
Topics: Carbon Radioisotopes; Carcinoma; Choline; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2015 |
(68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Topics: Adult; Aged; Biomarkers; Biomarkers, Tumor; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Receptors, Somatostatin | 2016 |
The incidence and sites of Nasopharyngeal carcinoma (NPC) metastases on FDG PET/CT scans.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Singapore; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
False-positive finding of retropharyngeal lymph node recurrence in both fluorine (18)FDG PET and MRI in a patient with nasopharyngeal carcinoma.
Topics: Adult; Biopsy; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2016 |
The key role of 18F-FDG PET/CT for correct diagnosis, staging, and treatment in a patient with simultaneous NPC and TB lymphadenitis: case report.
Topics: Adult; Antitubercular Agents; Biopsy, Fine-Needle; Combined Modality Therapy; Drug Therapy, Combination; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Male; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Treatment Outcome; Tuberculosis, Lymph Node | 2016 |
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carci
Topics: Carcinoma; Disease Progression; Disease-Free Survival; DNA, Viral; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Viral Load | 2015 |
(18)F-FDG Uptake Characteristics in Differentiating Benign from Malignant Nasopharyngeal Lesions in Children.
Topics: Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Male; Metabolic Clearance Rate; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |
The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiation Dosage; Radiopharmaceuticals; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Failure; Tumor Burden; Young Adult | 2016 |
Utility of 18F-FDG PET/CT in the assessment of lymphoepithelioma-like carcinoma.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Recurrence; Treatment Outcome | 2016 |
[A bluish sublimity of pharyngeal wall].
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperpigmentation; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Palatine Tonsil; Plasmacytoma; Positron Emission Tomography Computed Tomography; Tonsillar Neoplasms | 2016 |
Evaluation of Time-Phase Effect on 18F-FDG PET/CT Delineation Methods for Treatment Planning of Nasopharyngeal Carcinoma.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tumor Burden | 2016 |
Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Models, Theoretical; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2016 |
The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cells, Cultured; Drug Monitoring; Endostatins; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Mice; Nasopharyngeal Neoplasms; Neovascularization, Pathologic; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Recombinant Proteins; Reproducibility of Results; Xenograft Model Antitumor Assays | 2016 |
Prognostic utility of (18)F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site.
Topics: Adult; Aged; Biomarkers; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2016 |
Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
Topics: Carcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome; Viral Load | 2017 |
Synchronous presentation of nasopharyngeal carcinoma and abdominal paraganglioma with avid 18F-FDG and 68Ga-DOTA-TOC uptake in PET/CT by both tumours.
Topics: Abdominal Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasms, Multiple Primary; Organometallic Compounds; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution | 2016 |
Value of
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Unsuspected axillary lymph node metastasis of nasopharyngeal and cervical cancer on 18FDG PET/CT: a case report.
Topics: Axilla; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms; Whole Body Imaging | 2016 |
Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
[Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2008 |
18F-fluorodeoxyglucose uptake in different histological subtypes of nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; World Health Organization; Young Adult | 2009 |
[Analysis of standard uptake values of 18F-FDG PET/CT in relation to pathological classification and clinical staging of nasopharyngeal carcinoma].
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2008 |
Incidental detection of concurrent extramedullary plasmacytoma and amyloidoma of the nasopharynx on [18F]fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Nasopharyngeal Neoplasms; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma.
Topics: Adult; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Taiwan | 2009 |
Use of single MRI and 18F-FDG PET-CT scans in both diagnosis and radiotherapy treatment planning in patients with head and neck cancer: advantage on target volume and critical organ delineation.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Parotid Gland; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
Usefulness of 201TL SPECT/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma.
Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Logistic Models; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Probability; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Skull Base; Tomography, Emission-Computed, Single-Photon | 2009 |
Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2009 |
Tl-201 SPECT in clarifying false positive FDG PET findings caused by osteoradionecrosis in a case of nasopharyngeal carcinoma.
Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Recurrence; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2009 |
[18F-FDG PET/CT for the detection of primary tumors metastasizing to lymph nodes of the neck].
Topics: Adolescent; Adult; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Nasopharyngeal Neoplasms; Neck; Positron-Emission Tomography; Pyriform Sinus; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2009 |
[Relationship between fluorodeoxyglucose uptake and vascular endothelial growth factor in early-stage nasophygeal carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A; Young Adult | 2009 |
Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2010 |
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Retrospective Studies; ROC Curve; Sample Size; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Nasopharyngeal carcinoma: relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis and TNM classification.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Synchronous prostate cancer incidentally detected by FDG-PET/CT in staging a patient with newly diagnosed nasopharyngeal cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Early monitoring of radiotherapeutic effects of nasopharyngeal carcinoma xenografts in nude mice using 18F-FDG PET-CT imaging.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Positron-Emission Tomography; Random Allocation; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2010 |
Primary nasopharyngeal tuberculosis mimicking carcinoma: a potentially false-positive PET/CT finding.
Topics: Aged; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis | 2010 |
Nasopharyngeal carcinoma with splenic and cystic liver metastases in a pediatric patient: 18F-FDG PET-CT findings.
Topics: Adolescent; Carcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed | 2010 |
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Squamous Cell; Chemoradiotherapy; Choline; Cisplatin; Contrast Media; Diagnostic Imaging; Extracellular Space; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Gadolinium DTPA; Glucose; Glycolysis; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric; Tongue Neoplasms; Tonsillar Neoplasms | 2012 |
The role of pretreatment FDG-PET in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
Topics: Adult; Aged; Analysis of Variance; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Treatment Outcome; Young Adult | 2012 |
Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT.
Topics: Adult; Aged; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Plasma Epstein-Barr virus DNA screening followed by ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Combined Modality Therapy; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Young Adult | 2011 |
The utility of PET/CT in staging and assessment of treatment response of nasopharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Prediction of surgical outcome using plasma Epstein-Barr virus dna and (18)F-FDG PET-CT scan in recurrent nasopharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; DNA, Viral; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pharyngectomy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Retrospective Studies; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Differentiating osteoradionecrosis from nasopharyngeal carcinoma tumour recurrence using ⁹⁹Tcm-sestamibi SPECT/CT.
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Osteoradionecrosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Tumor Burden | 2011 |
Surgical management of radiation-induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: report of 14 cases.
Topics: Adrenal Cortex Hormones; Adult; Anesthesia; Carcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Headache; Humans; Intracranial Hypertension; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Temporal Lobe; Tomography, X-Ray Computed; Vertigo | 2011 |
Prognostic impact of standardized uptake value of F-18 FDG PET/CT in nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Reference Standards; Tomography, X-Ray Computed | 2011 |
A low F-18 FDG uptake in the nasopharynx plasmacytoma detected by FDG PET/CT.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nasopharyngeal Neoplasms; Nasopharynx; Plasma Cells; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Lower neck neurilemmoma can masquerade as lymph node metastasis on FDG PET/CT in patient with nasopharyngeal carcinoma.
Topics: Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neurilemmoma; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Dynamic PET-CT studies for characterizing nasopharyngeal carcinoma metabolism: comparison of analytical methods.
Topics: Adult; Aged; Algorithms; Blood Glucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Automatic detection and classification of nasopharyngeal carcinoma on PET/CT with support vector machine.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Support Vector Machine; Tomography, X-Ray Computed | 2012 |
A new brain positron emission tomography scanner with semiconductor detectors for target volume delineation and radiotherapy treatment planning in patients with nasopharyngeal carcinoma.
Topics: Adult; Aged; Bismuth; Brain; Carcinoma; Female; Fluorodeoxyglucose F18; Germanium; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Differential diagnosis of primary nasopharyngeal lymphoma and nasopharyngeal carcinoma focusing on CT, MRI, and PET/CT.
Topics: Adolescent; Adult; Aged; Carcinoma; Child; Contrast Media; Cross-Sectional Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Circulating EBV DNA and ¹⁸F-FDG PET scan in the diagnosis and monitoring of nasopharyngeal carcinoma.
Topics: Carcinoma; DNA, Viral; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Cell Differentiation; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2012 |
[Serial (18)F-FDG PET-CT imaging during radiotherapy for nasopharyngeal carcinoma: a prospective clinical study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, High-Energy; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2012 |
[Efficiency comparison between PET/CT and conventional work-up for evaluating distant metastasis of nasopharyngeal carcinoma].
Topics: Aged; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; DNA, Viral; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forecasting; Herpesvirus 4, Human; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sex Factors; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Viral Load | 2013 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |
Pretreatment (18)F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Young Adult | 2013 |
[Detection of residue of nasopharyngeal carcinoma with FDG PET].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Clinical value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting recurrent nasopharyngeal carcinoma at the parapharyngeal space after radiotherapy].
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging.
Topics: Adolescent; Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Increased metabolic activity in the spinal cord of patients with long-standing Lhermitte's sign.
Topics: Adult; Female; Fibroblasts; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Methionine; Nasopharyngeal Neoplasms; Radiation Injuries; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Spinal Cord; Spinal Cord Diseases; Time Factors; Tomography, Emission-Computed | 2003 |
[Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
False-positive findings on F-18 fluoro-2-deoxy-D-glucose positron emission tomography in a patient with nasopharyngeal carcinoma and extensive sinusitis.
Topics: Diagnosis, Differential; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sinusitis | 2005 |
Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome; Whole-Body Counting | 2005 |
Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2005 |
Extraordinarily high F-18 FDG uptake caused by radiation necrosis in a patient with nasopharyngeal carcinoma.
Topics: Carcinoma; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals | 2005 |
Effect of diazepam on the efficacy of dual-phase FDG PET imaging.
Topics: Administration, Oral; Carcinoma; Diazepam; Drug Interactions; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2006 |
[Value of 18F-fluorodeoxyglucose positron emission tomography in three-dimensional conformal radiotherapy for locally persistent or recurrent nasopharyngeal carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal | 2005 |
[18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Survival Analysis | 2006 |
[The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Palpation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2006 |
[Evaluation of CT, MRI and PET-CT in detecting retropharyngeal lymph node metastasis in nasopharyngeal carcinoma].
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Pharynx; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Influence of [18F] fluorodeoxyglucose positron emission tomography on salvage treatment decision making for locally persistent nasopharyngeal carcinoma.
Topics: Adult; Aged; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Tomography, X-Ray Computed | 2006 |
Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study.
Topics: Child; Child, Preschool; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Jaw Neoplasms; Lung Neoplasms; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rhabdomyosarcoma; Skull Neoplasms | 2006 |
18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Statistics, Nonparametric | 2006 |
[Diagnosis of recurrent or residual nasopharyngeal carcinomas in the skull base area with F-18-fluoro-deoxyglucose positron emission tomography].
Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Skull Base | 2006 |
Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Algorithms; Clinical Trials, Phase II as Topic; DNA, Viral; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Tomography, X-Ray Computed; Tumor Burden | 2006 |
Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; DNA, Viral; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Liver Neoplasms; Male; Nasopharyngeal Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Treatment Outcome | 2006 |
Utility of 18F-FDG PET/CT uptake patterns in Waldeyer's ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Subtraction Technique | 2007 |
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Child; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting.
Topics: Bone and Bones; Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Positron-Emission Tomography | 2007 |
[Clinical value of 18FDG-PET in diagnosing and detecting residue or recurrence of nasopharyngeal carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography | 2007 |
[Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2007 |
[The values of MRI, CT, and PET-CT in detecting retropharyngeal lymph node metastasis of nasopharyngeal carcinoma].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Pharynx; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2007 |
Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
Topics: Adult; Aged; Cyclic N-Oxides; Female; Fluorodeoxyglucose F18; Humans; Male; Mercaptoethanol; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2007 |
18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Outcome | 2008 |
Detection of thyroid metastases from nasopharyngeal carcinoma with F-18 FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
The prognostic significance of tumor vascular invasion and its association with plasma Epstein-Barr virus DNA, tumor volume and metabolic activity in locoregionally advanced nasopharyngeal carcinoma.
Topics: Cavernous Sinus; Combined Modality Therapy; DNA, Viral; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Hong Kong; Humans; Magnetic Resonance Imaging; Male; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome; Tumor Burden | 2008 |
Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Whole Body Imaging | 2009 |
Pitfalls of diagnosis based on abnormal flow cytometry and [(18)F]fluorodeoxyglucose positron emission tomography.
Topics: Adult; Flow Cytometry; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Male; Nasopharyngeal Neoplasms; Positron-Emission Tomography | 2008 |
Functional imaging of head and neck tumors using positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cerebellum; Cicatrix; Deoxyglucose; Female; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Pituitary Neoplasms; Tomography, Emission-Computed; Tonsillar Neoplasms | 1994 |
Positron emission tomographic imaging of head and neck lesions.
Topics: Absorption; Adenoma; Aspergillosis; Carcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Deoxyglucose; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Head and Neck Neoplasms; Histiocytoma, Benign Fibrous; Humans; Magnetic Resonance Imaging; Maxillary Sinus; Maxillary Sinus Neoplasms; Maxillary Sinusitis; Nasopharyngeal Neoplasms; Papilloma; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 1997 |
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 1998 |
Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Detection of unknown primary cancer with fluor-deoxy-glucose positron emission tomography.
Topics: Biopsy, Needle; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[Diagnosis of recurrent or persistent nasopharyngeal cancers inspite of radiotherapy: Comparison of F-18-deoxyglucose positron emission tomography with computed tomography].
Topics: Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Failure | 1999 |
Fluorine-18 FDG positron emission tomography in advanced nasopharyngeal carcinoma.
Topics: Adult; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Early detection of bone marrow involvement in extramedullary plasmacytoma by whole-body F-18 FDG positron emission tomography.
Topics: Adult; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Plasmacytoma; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma.
Topics: Adult; Aged; Biopsy; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neck; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiography; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed | 2002 |